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Abstract: Phosphate-based glasses (PBGs) offer significant therapeutic potential due to their bioactiv-
ity, controllable compositions, and degradation rates. Several PBGs have already demonstrated their
ability to support direct cell growth and in vivo cytocompatibility for bone repair applications. This
study investigated development of PBG formulations with pyro- and orthophosphate species within
the glass system (40 − x)P2O5·(16 + x)CaO·20Na2O·24MgO (x = 0, 5, 10 mol%) and their effect on
stem cell adhesion properties. Substitution of phosphate for calcium revealed a gradual transition
within the glass structure from Q2 to Q0 phosphate species. Human mesenchymal stem cells were
cultured directly onto discs made from three PBG compositions. Analysis of cells seeded onto the
discs revealed that PBG with higher concentration of pyro- and orthophosphate content (61% Q1
and 39% Q0) supported a 4.3-fold increase in adhered cells compared to glasses with metaphosphate
connectivity (49% Q2 and 51% Q1). This study highlights that tuning the composition of PBGs
to possess pyro- and orthophosphate species only, enables the possibility to control cell adhesion
performance. PBGs with superior cell adhesion profiles represent ideal candidates for biomedical
applications, where cell recruitment and support for tissue ingrowth are of critical importance for
orthopaedic interventions.
Keywords: biomaterials; stem cells; phosphate-based glasses; cell culture; material degradation
1. Introduction
In regenerative medicine, restoration of biological function can be aided by biomate-
rials created from metals, ceramics or polymers offering a variety of chemical structures,
surface properties, degradation rates, and mechanical stiffness [1,2]. These properties
allow for material functionalization to promote cell adhesion, support cell differentiation,
exert anti-microbial effects, and assist drug delivery, among other applications [3–5]. Phos-
phate based glasses (PBGs) are biomaterials of particular interest due to their complete
yet controllable resorption profiles which can be modified by simply altering the mate-
rials composition [6,7]. Glass is typically composed of network formers such as silicon
or phosphate linked together through bridging oxygen atoms [8]. PBGs use phosphate
(P2O5) as the network former, which can be structurally disrupted through the introduction
of network modifier oxides which form non-bridging oxygen atoms [9]. The number of
bridging oxygen atoms per tetrahedra, which define the Qn-speciation, are progressively
broken down as network modifiers are added to the composition, decreasing connectivity
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within the glass [10]. Through modifications of the glass composition, it is entirely possible
to influence a gradual decrease in structural connectivity (Q3 to Q0) which is denoted
respectively as ultra-, meta-, pyro-, and orthophosphates [11–13].
When a higher percentage of P2O5 is incorporated in the composition, more than
50 mol%, the resulting glass possesses an ultraphosphate structure. However, when
the P2O5 content remains at 50 mol% the resulting phosphate glass mainly contains Q2
(metaphosphate) species and when the P2O5 content is reduced further to below 50 mol%
the glass transitions towards Q1 (pyrophosphate) species; where these formulations are
referred to as invert glasses [9,13]. The glasses composed of higher amounts of phosphate
content often degrade too fast for use as stable implants. Whereas invert glasses have the
advantage of slower and more controlled degradation rates, with multicomponent glasses
showing very little degradation after immersion in aqueous solutions [14]. Phosphate
invert glasses consist of pyrophosphate (Q1) and orthophosphate (Q0) species, where upon
eventual degradation it is anticipated that these two phosphate anions would be released.
The key advantage of these ions are that they are found naturally within the body and
can act towards beneficial support to regeneration and homeostasis of bone and other
tissues [15].
It has been reported that when binding to hydroxyapatite (HA) which is composed
of orthophosphate anions, inorganic pyrophosphate (PPi) can inhibit mineralisation by
blocking further attachment and preventing the growth of crystals. While this could be
problematic and disadvantageous for successful regeneration of bone architecture, py-
rophosphate anions also contribute towards the homeostasis of bone [16,17]. The majority
of extracellular PPi will interact with pyrophosphatases such as alkaline phosphatase
(ALP) and tissue non-specific alkaline phosphatases (TNAP), enzymes which can be found
bound to osteoblast cells and within matrix vesicles that are released [18]. Enzyme inter-
actions cause PPi hydrolysis which consequently enables formation of orthophosphate
(Q0) ions [19]. These orthophosphate ions are crucial for successful formation of bone HA
crystals and are utilised in mineralisation of the collagen matrix previously laid down
by the osteoblasts engaging in new bone formation [20]. This PPi degradation pathway
is a promising avenue to explore for enhancing bone formation since it utilises naturally
available mechanisms to generate two orthophosphate anions from each pyrophosphate
molecule, thereby influencing the dynamic remodelling cycle.
As PBGs can incorporate various oxides as network modifiers, careful selection of
specific oxides can confer cellular benefits when released, in addition to modifying glass
properties [21]. For example, incorporation of calcium conveys the advantage of not
only nucleating and mineralizing matrix through its release, but also directly influencing
osteoblasts through calcium sensing receptors [22,23]. Magnesium has also been shown
to play a key role in angiogenesis and formation of the ALP enzyme [24–26]. Phosphate
species such as pyrophosphates have been demonstrated to promote ALP activity and
gene expression [17]. Several studies have reported the supplementation of PBGs with
strontium and zinc among other ions, demonstrating the variety of PBG compositions
and applications [27–29]. Furthermore, the osteogenic effect of inorganic ions recently
underlined the ability of PBG fibers to facilitate proliferation and osteogenic gene expression
through the release of dissolution products [30]. Additional studies have demonstrated
the biocompatibility and antimicrobial activity of PBG, and suggested their suitability for
wound healing applications [31–34].
The controllable degradation rates of PBGs is a key asset to mimic the elevated levels
of calcium and phosphate seen at sites of bone resorption, promoting regeneration of
bone [15,35]. Additionally, PBGs can be manufactured to suit a variety of geometries. For
example, PBGs in microsphere form allow for superior defect filling, scaffolding and flow
properties, offering minimally invasive delivery routes [34,36,37]. A therapeutic product
which is injectable, biocompatible, and can support osteogenic cells could prove highly
effective to combat the degenerative nature of some bone diseases such as osteoporosis,
potentially inhibiting or reversing bone loss subsequently resulting in reduced fracture
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risk [38]. To fulfil defect filling and tissue scaffolding roles, PBGs need to provide an ideal
surface for cell adhesion. This study explores the tailoring of phosphate species in PBG
formulations [34,36] to improve cell adhesion properties as it hypothesized that PBGs
containing high pyro- and orthophosphate content would achieve superior results. As
such, three PBGs of varying pyro- and orthophosphate content ratios were produced and




To confirm the composition of the different PBGs produced, EDX analysis was per-
formed on each formulation and the measurements for P40, P35 and P30 confirmed that
the materials were within 1–4 mol% of the target formulation with a maximum deviation
in percentage difference revealed to be 1.7 mol% (Table 1). P2O5 was substituted for the
equivalent mol% CaO through the formulations, while the concentrations of MgO and
NaO remained unchanged.
Table 1. EDX measurements of glass compositions against target formulation (mol%) ± standard









P40 Target 40 16 24 20
Measured 39.4 ± 0.7 16.6 ± 0.6 24.0 ± 0.6 20.0 ± 0.7
P35 Target 35 21 24 20
Measured 34.0 ± 0.4 25.5 ± 1.7 21.9 ± 1.0 18.7 ± 0.7
P30 Target 30 26 24 20
Measured 28.2 ± 0.3 24.3 ± 0.7 26.0 ± 0.5 21.6 ± 0.5
Thermal analysis was carried out via differential scanning calorimeter (DSC) analysis
to determine the thermal properties of the glasses explored, in particular, the glass transition
(Tg), crystallisation (Tc), and melting (Tm) temperatures of each formulation as phosphate
content was decreased. Figure 1a shows the DSC profiles of the three formulations and
the Tg, Tc, and Tm values are presented in Table 2. Phosphate content substitution for
calcium resulted in increases in Tg by 31 ◦C between P40 and P35 and a further increase
of 9 ◦C between P35 and P30. Of the glasses tested, both P40 and P35 revealed a single
crystalline peak with a Tc of 592 ◦C decreasing to 557 ◦C while P30 revealed a sharp
single crystallisation peak at 578 ◦C and a smaller peak at 654 ◦C. These peaks indicated
the possible presence of multiple crystalline phases existing within the respective glass
formulations produced. The thermal processing window provides insight into the materials
stability i.e., the resistance of a glass to crystallisation. Between P40 and P35 the processing
windows were observed to have shortened dropping from 118 ◦C to 57 ◦C supporting the
tendency towards crystallisation observed in low phosphate glasses as P30 also showed a
processing window shorter than that of P40 at 68 ◦C.
X-ray powder diffraction (XRD) was carried out to confirm the nature of the formula-
tions produced, which revealed the absence of crystalline peaks for all three formulations
and the presence of a broad ‘halo’ peak characteristic of the amorphous nature of the
glasses (Figure 1b).
Nuclear magnetic resonance (NMR) analysis was used to confirm the distribution
of different Qn phosphate species within the three PBG formulations. As the phosphate
content decreased from 40 mol% to 30 mol%, the phosphate species found within the glass
structure decreased from Q2 and Q1, meta- and pyrophosphates, to Q1 and Q0, pyro- and
orthophosphates. The NMR spectra for P40 showed two dominant peaks representing Q1
(−8.6 ppm) and Q2 (−22.8 ppm) units [9,39] (Figure 2).
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Figure 1. Glass characterization of P40, P35, and P30. (a) Thermal analysis traces via differential scanning calorimeter 
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X-ray powder diffraction (XRD) was carried out to confirm the nature of the 
formulations produced, which revealed the absence of crystalline peaks for all three 
formulations and the presence of a broad ‘halo’ peak characteristic of the amorphous 
nature of the glasses (Figure 1b). 
Table 2. Glass transition (Tg), onset of crystallisation (Tc), melting temperature (Tm), and calculated thermal processing 














Tconset − Tg 
P40 445 563 592  761 838 118 
P35 476 533 557 637 805 853 57 
P30 485 553 578 654 790 825 68 
Nuclear magnetic resonance (NMR) analysis was used to confirm the distribution of 
different Qn phosphate species within the three PBG formulations. As the phosphate 
content decreased from 40 mol% to 30 mol%, the phosphate species found within the glass 
structure decreased from Q2 and Q1, meta- and pyrophosphates, to Q1 and Q0, pyro- and 
orthophosphates. The NMR spectra for P40 showed two dominant peaks representing Q1 
(−8.6 ppm) and Q2 (−22.8 ppm) units [9,39] (Figure 2). 
Figure 1. Gl ss characteriz tion of P40, P35, and P30. (a) Thermal nalysis tr ces via differential
scanning calorimeter (DSC) of the phosphate-based glasses (PBG) formulations showing Tg, Tc, and
Tm. (b) XRD spectra confirming the amorphous nature of P40, P35, and P30 glasses produced.
Table 2. Glass transition (Tg), onset of crystallisation (Tc), m lting temperature (Tm), nd calculated















P40 445 563 592 761 838 118
P35 476 533 557 637 805 853 57




Figure 2. 31P nuclear magnetic resonance (NMR) spectra of the P40, P35, and P30 formulations. 
P35 also demonstrated similar peaks identified as Q1 (7.4 ppm) and Q2 (−21.3 ppm) 
units. The slight shift in peaks associated with the Q2 species was suggested to be due to 
substitution of 5 mol% phosphate for calcium and a decrease in Q2 species content from 
49% to 6% followed by equivalent increases in Q1 species from 51% to 94%. When the level 
of phosphate content was further decreased to 30 mol% in the P30 formulation, a shift 
from Q2 and Q1 to Q0 (3.3 ppm) fractions was observed, indicating presence of 
orthophosphate content, which was absent from the other two formulations explored 
revealing a Q1 to Q0 ratio of 61% and 39%, respectively (Table 3). 
Table 3. Distribution of Qn species across PBG formulations. 
 Q0 Q1 Q2 
P40 0 51 49 
P35 0 94 6 
P30 39 61 0 
2.2. Cell Adhesion 
An in vitro analysis was conducted to identify the impact of altering phosphate and 
calcium content of PBG on their capacity for stem cell adhesion and viability, comparing 
the effect of varying meta-, pyro-, and orthophosphate content. To this end, green 
fluorescence protein (GFP)-labelled MSCs were seeded onto discs (9 mm × 2 mm) made 
from the three PBG formulations, with tissue culture plastic (TCP) as a control, and 
cultured for 24 h. MSCs were able to attach to all three formulations tested, however, there 
were notable differences (Figure 3).  
0100200











Figure 2. 31P nuclear magnetic r sonance (NMR) spect a of the P40, P35, and P30 formulations.
P35 also demonstrated similar peaks identified as Q1 (7.4 ppm) and Q2 (−21.3 ppm)
units. The slig t s ift in peaks associated with the Q2 species was suggested to be due to
substitution of 5 mol% phosphate for calcium and a decrease in Q2 species content from
49% to 6% followed by equivalent increases in Q1 species from 51% to 94%. When the level
of phospha content w s further decreased t 30 mol% in the P30 formulation, a shift from
Q2 and Q1 to Q0 (3.3 ppm) fractions was observed, indicating presence of orthophosphate
content, which was ab ent f om the other two formulations explored revealing a Q1 to Q0
ratio of 61% and 39%, respectively (Table 3).
Table 3. Distribution of Qn species across PBG formulations.
Q0 Q1 Q2
P40 0 51 49
P35 0 94 6
P30 39 61 0
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2.2. Cell Adhesion
An in vitro analysis was conducted to identify the impact of altering phosphate and
calcium content of PBG on their capacity for stem cell adhesion and viability, comparing the
effect of varying meta-, pyro-, and orthophosphate content. To this end, green fluorescence
protein (GFP)-labelled MSCs were seeded onto discs (9 mm × 2 mm) made from the three
PBG formulations, with tissue culture plastic (TCP) as a control, and cultured for 24 h.
MSCs were able to attach to all three formulations tested, however, there were notable
differences (Figure 3).




Figure 3. Cell adherence analysed 24 h after seeding on P40, P35, P30, and tissue culture plastic (TCP) surfaces. (a) 
Representative fluorescent images showing green fluorescence protein (GFP)-labelled mesenchymal stem cells (MSCs) 
(green) and Hoechst stained nuclei (blue). (b) Metabolic activity assay (norm-TCP shows activity for cells seeded onto TCP 
normalized to disc surface area). (c) Average nuclei count per field of view at 24 h. (d) Average percentage of rounded 
cells per field of view at 24 h. Scale bar = 250 μm. a.u.: arbitrary fluorescence units. * p < 0.05, ** p < 0.01, *** p < 0.001 and 
**** p < 0.0001. (n = 3). 
Figure 3. Cell adherence analysed 24 h after seeding on P40, P35, P30, and tissue culture plastic (TCP)
surfaces. (a) Representative fluorescent images showing green fluorescence protein (GFP)-labelled
mesenchymal stem lls (MSCs) (green) and Hoechst stained nu lei (blue). (b) Metabolic activity
assay (norm-TCP shows activity for cells seeded onto TCP normalized to disc surface area). (c)
Average nuclei count per field of view at 24 h. (d) Average percentage of rounded cells per field of
view at 24 h. Scale bar = 250 µm. a.u.: arbitrary fluorescence units. * p < 0.05, ** p < 0.01, *** p < 0.001
and **** p < 0.0001. (n = 3).
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As the phosphate content decreased from 40 mol% to 30 mol%, an increasing number
of cells remained adhered to the glass disc surface (Figure 3a). The number of adherent
cells increased in the order P30 > P35 > P40, and this was supported by results from
the metabolic activity and nuclei count assays performed at 24 h, the latter showing a
significant 4.3-fold increase in cells counted (Figure 3b,c). Furthermore, many of the cells
on the P40 formulation displayed a rounded morphology, characteristic of cells with low
substrate attachment [40]. By comparison, the proportion of these rounded cells decreased
significantly on the P35 and P30 formulations (Figure 3d).
3. Discussion
Among the wide range of biomaterials being developed for orthopedic applications,
PBGs offer significant advantages in terms of geometric and chemical versatility, which
make them well-suited for regenerative medicine applications [27,34,41]. Importantly, PBGs
can be produced as porous microspheres, which allows for injectable, minimally invasive
delivery for defect filling applications while offering high surface area for enhanced cell
adhesion and increased release kinetics [37,38]. While the use of various biocompatible
coatings, such as collagen, can offer a means to ensure cell adhesion to biomaterials [42,43],
the ability of specific PBG formulations to influence cell attachment without the use of
ancillary biological components underlines their potential for clinical applications. As
such, PBG microspheres are promising candidates for new orthopaedic therapies seeking
to promote tissue repair [15], particularly in cases of bone loss where an increased risk
of fracture is prevalent [44]. The high surface area and defect filling capacity of porous
microspheres can promote cell-material interactions and tissue integration through and
around microsphere clusters as previously observed in vitro [27] and in vivo [34]. This cell-
material interaction naturally hinges on the capacity of the glass to promote cell adhesion
and bone tissue formation.
To contribute towards the formation of new bone tissue during regeneration, phos-
phate anions as well as calcium and magnesium cations are essential. Within the natural cy-
cle of bone resorption and formation, both pyro- and orthophosphates have an established
role that can be directed towards the generation of new bone and HA crystallisation [45,46].
Inorganic pyrophosphates can act to modulate biomineralization, behaving both as an
inhibitor for mineral formation and as a source of orthophosphates once hydrolysed by
ALP [20,47]. In addition, they have been shown to stimulate the differentiation of pre-
osteoblasts whilst also encouraging stimulation of ALP activity and extracellular matrix
gene expression [17], and the presence of orthophosphate anions is directly linked to bone
formation, as they are instrumental in the natural process for the mineralisation of collagen
fibers which are laid down by osteoblasts during bone remodelling [19]. Phosphate-based
glasses hold significant potential for bone regeneration, offering support for the biominer-
alisation process through their modifiable chemical composition and releasing beneficial
ions at controllable rates in aqueous environments [48–50].
3.1. Material Characterisation
Compositional analysis of P40, P35, and P30 using EDX confirmed their composition
to be within 1–4% of the target formulation. This is in line with other PBG investigated in
the literature, particularly P40 [41]. No crystallisation peaks were observed for all three
glass formulations, confirming their amorphous structure. Thermal analysis indicated a
linear increase in Tg as phosphate content was substituted for calcium. This was likely
due to the increase in divalent calcium cations, resulting in increased cross-linking of the
phosphate chains within the glass structure [51–53]. This correlates with data presented by
Franks et al. [54] who demonstrated a linear increase in Tg as calcium was added to the
45P2O5·(8 + x)CaO·(47 − x)Na2O (x = 2–32) PBG system, and by Ahmed et al. [55] who
demonstrated a similar linear increase in Tg with calcium addition into the PBG system
50P2O5·(50 + x)CaO·(x)Na2O (x = 0–50). A similar shift in phosphate species was also
reported in a study where the phosphate content of the quaternary glass CaO-P2O5-TiO2-
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Na2O was reduced from 55 mol% to 28 mol% [56]. The glasses that possessed a phosphate
content between 55 mol% and 40 mol% demonstrated the phosphate species Q2 and Q1
while a further decrease in phosphate content to 35 mol% resulted in a glass that consisted
of mainly Q1 pyrophosphates. Moreover, continued decreases in the phosphate content
to 30 and 28 mol% resulted in glasses possessing only Q1 and Q0 phosphate units within
the structure. The Qn species distribution of all three PBGs aligned closely with the model
predictions defined by Wazer and Fluck [57] as demonstrated by Figure 4.
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3.2. Cell Adhesion
Cell adhesion was analysed using polished glass discs to evaluate the impact of the
phosphate to calcium substitutions on the cell response to the material. All formulations
were shown to support cell adhesion, with P30 demonstrating the highest capacity for cell
adhesion and P40 demonstrating the lowest in comparison. These results are likely due to
the combination of two factors, ion–cell interactio s and material degradation.
Io –cell in eraction ca occur through number of mechanisms: (i) Calcium ions
triggering th macromolecular calcium-sensing receptor (CaSR)/integrin c mplexes that
promote adhesion [58] (ii) Direct divale t cation binding, particularly α-subunit containing
integrins [59]. It is worth noting that in addition to calcium all the disc formulations
used also contained magnesium, which is also a divalent cation, and could be capable of
activating the low conformation state of the heterodimer integrins [60].
In addition to ion–cell interactions, material degradation properties are also likely to
play a role in the results observed due to the impact degradation has on the local micro-
environment, such as causing changes to pH and osmotic pressure. Abou Neel et al. [61]
showed increased adhesion and proliferation rate of an osteosarcoma cell line (MG63) on
PBG discs containing increasing mol% of titanium (0–5% in CaO·Na2O·P·Ti). On day 4,
glasses without titanium content showed a significant decrease in proliferation compared
to the formulati containing 5% titanium. Bitar et l. [62] also demo str t increased
adhesio and proliferation of human osteoblasts on PBG discs with increasing mol% of
calcium through Na2O s bstitution for CaO (30–34% in Ca ·Na2O·P2O5). Glasses with
less than 40% CaO (in favour of increased Na2O) supported little to no cell adhesion after
24 h. A common correlation with these studies and the observations presented here, was
an increase in cellular adhesion with decreasing glass solubility. The addition of titanium
and substitution of Na2O for CaO would decrease the solubility of the respective glasses,
as seen with the P2O5 for CaO substitution in this study. This data is further supported
by a previous report [43] pointing to the deleterious nature of a rapidly degrading glass
surface through scanning election microscopy and viability analysis of MSC, which demon-
strated higher DNA content when the glass with the most CaO (40–48% CaO·2Na2O·50P)
was used.
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Studies investigating the degradation of invert glasses (37P2O5·29CaO ·10MgO·24Na2O)
which took place over 56 weeks, revealed a cumulative weight loss of only 25% over
one year in simulated body fluid [49]. Additionally, when compared to metaphosphate
glasses, invert glasses demonstrated ion release rates that were more than an order of
magnitude lower (2 mM vs. 80 mM phosphate) [63]. The P30 formulation tested in this
study demonstrated increased pyro- and orthophosphate content when compared to P35
and P40 which consist of only pyro- and metaphosphates. As such, it is likely that P30
possesses favorable dissolution rates as observed in other invert glasses and therefore
supported enhanced cell adhesion due to minimal changes to material surface integrity
and pH/osmolarity. Navarro et al. [6] suggested that local variations in the liquid envi-
ronment near the glass surface may be negatively impacting cells due to concentrated
changes in pH and ionic levels. Skelton et al. [43] who showed increased cell adhesion in
a formulation containing more calcium mol% (48 mol%) than other formulations in the
50P·(40 + x)CaO·(10 − x)Na2O glass system, suggested similar reasons for cell loss, cit-
ing potential contribution from factors such as surface integrity, ion–cell interactions and
pH/osmolarity change at the material-cell interface. A study by Tošić et al. [64] using scan-
ning electron micrograph images of an immersed glass surface, demonstrated disruption
of the glass surface through the formation of pits followed by their expansion in size and
number by 24 h. Naturally, a slower degrading glass would result in a more stable glass-
medium interface. In addition to this, the breakdown of physical surface of the glass itself
would likely impair adhesion events. The increased pyro- and orthophosphate content
within the P30 formulation ultimately allowed for a more stable glass surface, promoting
cell adhesion through the avoidance of the pH/osmolarity fluctuations suggested by other
studies. One question of interest for future characterisation will be to what extent the cell
attachment achieved on the PBG can in turn affect its rate of degradation.
3.3. Impact beyond Cell Adhesion
P30 demonstrated a significant increase in cell adhesion number in comparison to
P35 and P40. While cell adhesion and therefore colony establishment on PBG are critical,
particularly in patients with decreased stem cell counts, subsequent mechanisms to promote
bone formation are of equal importance. Due to its composition, P30 demonstrated a high
percentage of orthophosphates (~40%), the remaining structure made up of pyrophosphates
that can be advantageous when used in bone regeneration, providing support for growth of
HA crystals when hydrolysed by the osteoblast enzyme ALP, while stimulating osteoblast
differentiation and metabolic activity [17,20]. In addition, the inorganic pyrophosphate
structure possesses considerable similarity to the organic bisphosphonate drugs used in
the treatment to prevent excessive bone resorption by osteoclasts. The backbone of the
drugs are organic pyrophosphate molecules which are used as a “bone hook” to bind to
existing HA whereupon the drugs are internalised by osteoclasts during resorption leading
to cell death and an overall shift in bone homeostasis towards new bone formation [65,66].
Similarly, exposure to inorganic dicalcium pyrophosphates (1× 10−4 M) has been shown to
cause differential effects in bone cells specifically demonstrating an increase in osteoblasts,
while the cell count for osteoclasts decreased; a response that was attributed to the cells
having undergone apoptosis due to the incorporation of pyrophosphates [66]. To determine
the benefits of pyrophosphate inclusion, studies have concluded that its addition to calcium
phosphate cement implants allowed the pyrophosphate to act as a substrate for osteoblast
membrane ALP and encouraged the formation of HA over 12 months [20]. Moreover,
different concentrations of pyrophosphate have been shown to stimulate pre-osteoblast
differentiation and increase the peak ALP activity. At the highest concentrations (100 µM),
increased expression of osteogenic genes including Collagen 1, ALP, and Osteocalcin was
observed indicating the influence of pyrophosphate upon osteoblast differentiation [17,20].
It will thus be of interest to monitor osteogenic markers, including ALP, in cells exposed
to P30.
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Additionally, calcium orthophosphates have been incorporated as part of numerous
biomaterials due to their similarity to naturally occurring HA in bone tissue [34]. Inclusion
of calcium orthophosphates in new biomaterials for bone applications represents a nontoxic
component that would exhibit bioactive behaviour and allow for osteointegration, aiding
integration with living tissue [67]. When combined with collagen, calcium orthophosphates
represent an effective osteoconductive material enhancing osteoblast differentiation and
accelerating osteogenesis [68].
The modulation of their composition naturally changes the structure of phosphate-
based glass and can influence the phosphate species present within the material that
are eventually released as anions and made available to the local environment. The
changes in cell response reported here highlight how the adhesion profile of a glass
can be controlled and improved through tailoring of the ionic species present within its
composition. The present in vitro results call for complementary investigations of in vivo
parameters representing the complex nature of the bone environment which consists
of numerous cell types, metabolites, pH and ionic conditions that can further influence
cell adhesion, and will inform future clinical trials. Based on P30′s strong cell adhesion
profile, future studies will evaluate whether this new material may also enhance osteoblast
differentiation and support bone formation in vivo.
4. Materials and Methods
The reagents used in this study were purchased from ThermoFisher Scientific (Lough-
borough, UK) unless otherwise stated.
4.1. PBG Production
The precursors P2O5, NaH2PO4, CaHPO4, and MgHPO4·3H2O (Sigma Aldrich, Gilling-
ham, UK were used to fabricate PBGs of the system (40 − x)P2O5·(16 + x)CaO·20Na2O·24MgO,
where x is 0, 5 and 10 mol% (Table 4) [38]. The precursors were mixed and placed within a
100 mL Pt/5% Au crucible (Birmingham Metal Company, Birmingham, UK). The crucible
was then placed in a 350 ◦C furnace for 30 min, ramped to 460 ◦C for 30 min (10 ◦C/min)
then held for 30 min. A second ramp (10 ◦C/min) to 1150 ◦C was then reached and held for
90 min. The melts were poured onto a steel plate. A splat quench technique was performed
on P30 to avoid surface crystallisation effects.
Table 4. Glass composition (mol%).
Glass Code P (mol%) Ca (mol%) Mg (mol%) Na (mol%)
P40 40 16 24 20
P35 35 21 24 20
P30 30 26 24 20
To manufacture microspheres, a planetary zirconia ball mill (Retsch Planetary Mill
PM100) was used to grind the quenched glass for 3 min at 350 rpm at least 3 times.
Stainless steel sieves (VWR International, Lutterworth, UK) were then used to sieve the
glass particles into a size range of 63–125 µm. Porous PBG microspheres were prepared
by mixing the glass powders with CaCO3 in a 1:3 ratio before the flame spheroidisation
process using a thermal spray gun. After cooling, the microspheres were collected from
the cooling trays and porous microspheres were washed in 5 mM acetic acid for 2 min
followed by a deionized water wash for 5 min and then dried in a 50 ◦C oven for 24 h.
To produce glass discs, molten glass from each formulation was poured into graphite
moulds with 9 mm diameter rod cut outs and held at 10 ◦C above the glass transition
temperature (Tg) for each composition for 1 h before being allowed to cool to room tem-
perature overnight. After cooling, the glass rods were removed from the moulds and cut
using a diamond saw blade (Low Speed Diamond Wheel Saw Model 650 CE, South Bay
Technology Inc., San Clemente, CA, USA) to 2 mm width. Metallographic abrasive paper
(P240, P400, P800 and P1200), followed by 6 µm and 1 µm polishing pads and diamond
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pastes were used to polish the surfaces of the glass discs. Industrial methylated sprit was
used as a lubricant. Once prepared, the discs were sterilized through two 15-min washes
in ethanol 70% and allowed to dry for 24 h at room temperature in a sterile environment.
4.2. Energy-Dispersive X-ray Spectroscopy
Microspheres were embedded in resin (EpoFix Resin and Epofix Hardener, Struers,
Cleveland, OH, USA) before 10 nm carbon coating. Samples were then analysed at a
10 mm working distance using a 10 kV beam using a XL30 SEM (FEI/Philips, Amsterdam,
The Netherlands).
4.3. Thermal Analysis
A Differential Scanning Calorimeter (DSC, TA instruments, New Castle, DE, USA,
Q600) was used to determine the glass transition (Tg), onset crystallisation (Tcons), peak
crystallisation (Tc), and glass melting temperature (Tm) points of the produced glass
formulations. The processing window for the different glasses was determined using the
following equation:
Processing window = (Tcons − Tg)
20 mg of powdered glass samples were added to a platinum sample pan and heated
from room temperature to 1100 ◦C at a ramp of 10 ◦C/min. A second blank platinum pan
was used for a baseline to correct the thermal traces of the samples.
4.4. X-ray Powder Diffraction
XRD was used to confirm the amorphous nature of the PBGs produced. Ground glass
powder samples were run using a DVA-Da Vinci Advantage over a 2 theta range from
5 degrees to 70 degrees with a 0.02 degree step size and a step time over 4 s.
4.5. Nuclear Magnetic Resonance
NMR was used to resolve the distribution of different Qn species within the PBGs
produced. Solid-state 31P NMR spectra were recorded for the PBGs at room temperature
using a Varian Chemagnetics Infinity plus spectrometer operating at a Larmor frequency
of 121.47 MHz using a 4 mm magic angle spinning (MAS) probe spinning at 12 kHz. The
31P π/2 pulse duration was 3.7 µs, the spectral width was 100 kHz and the acquisition time
was 10.24 ms. Chemical shifts are quoted relative to 85% H3PO4. Prior to acquiring 31P
spectra the spin-lattice relaxation time T1 was determined for each sample by saturation
recovery. Saturation was achieved by 100 31P π/2 pulses spaced by delays of 5 ms with
recovery delays of up to 1000 s. Quantitative 31P NMR spectra required relaxation delays
(5 T1) of between 500 s and 650 s. The resulting spectra were deconvoluted into a set of
Gaussian line shapes which were integrated in order to quantify the proportions of the
different Q environments in the sample. First-order MAS sidebands were included in
the analysis.
4.6. Cell Culture
For the direct culture study, a human immortalized bone marrow-derived mesenchy-
mal stem cell line (MSC) labelled with Green Fluorescence Protein (as previously described
in Harrison et al., 2017; Macri-Pellizzeri et al., 2018) was seeded onto sterilized discs at
a density of 8000 cells/cm2 in standard cell culture medium (SM) (low glucose DMEM
supplemented with 10% Foetal calf serum (FCS), 1% penicillin and streptomycin, 1% L-
Glutamine, and 1% non-essential amino acids) and cultured at 37 ◦C and 5% CO2 for 24 h.
Cells seeded on tissue culture plates (TCP) were used as a control.
4.7. Metabolic Activity Assay
After 24 h of culture, the cell-seeded discs of each formulation were transferred to
a new 48-well plate and the metabolic activity of seeded cells was analyzed using the
Presto blue Cell Viability Reagent following the manufacturer’s instructions. Briefly, a
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working solution of 10% of Presto Blue reagent in SM was prepared and 300 µL was added
to the cells after one PBS wash. After 45 min incubation in the dark at 37 ◦C and 5% CO2,
250 µL of the solution were then transferred to a new 96-well plate for the measurement of
fluorescence at 560 nm and 590 nm the excitation and emission wavelengths, respectively
using a plate reader Infinite 200 (Tecan, Reading, UK). Values were normalized to the
surface area to allow comparison with cells cultured on TCP.
4.8. Nuclear Staining and Imaging
After 24 h in culture, live cell nuclei were stained using Hoechst 33258 (Sigma-Aldrich,
Gillingham, UK) at 20 µg/mL in SM for 1 h at 37 ◦C. Bright field images were taken using a
Nikon Eclipse TS100 microscope, and fluorescent images were taken on a Nikon Eclipse TS2
microscope. Cell nuclei and cells displaying a rounded morphology were manually counted
from four fields of view per disc using NHI ImageJ 1.8.0. (https://imagej.nih.gov/).
4.9. Statistical Analysis
Results for the metabolic activity assay and nuclei counts are presented as mean± stan-
dard error of the mean (SEM). One-way analysis of variance with Turkey’s multiple
comparison test was used. A 95% confidence level was considered significant. Graphs
and statistical analysis were performed using GraphPad PRISM 7.04 software package
(https://www.graphpad.com/, GraphPad Software, San Diego, CA, USA). * p < 0.05,
** p < 0.01, *** p < 0.001 and **** p < 0.0001.
5. Perspectives
The PBG discs demonstrated a linear response of increasing stem cell adhesion as
phosphate was substituted for calcium, with P30 demonstrating a significant increase in
adherent cells compared to the P40 formulation. This trend in cell adhesion was linked to
the high concentration of pyro- and orthophosphate content in P30, resulting in a more
stable and favorable glass surface for cell adhesion when compared to both P35 and P40.
The initial phase of progenitor cell seeding and culture establishment in in vivo applications
is of critical to initiate the tissue repair process. This study demonstrates the successful
tailoring of PBG formulation through increases in pyro- and orthophosphate species within
the glass to enhance stem cell adhesion and support cell culture. In addition to providing a
supporting surface for cell adhesion, the potential benefits of inorganic ions and phosphate
species released from the PBG represent a promising resource for orthopaedic and tissue
repair applications.
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DSC Differential scanning calorimeter
FCS Foetal calf serum
GFP Green fluorescence protein
HA Hydroxyapatite
MSC Mesenchymal stem cell
NMR Nuclear magnetic resonance
PBG Phosphate based glass
PPi Inorganic pyrophosphate
SEM Standard error of the mean
Tc Glass crystallisation temperature
TCP Tissue culture plastic
Tg Glass transition temperature
Tm Glass melting temperature
TNAP tissue non-specific alkaline phosphatases
XRD X-ray powder diffraction
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